Intended for healthcare professionals

Editorials

Solanezumab and the amyloid hypothesis for Alzheimer’s disease

BMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i6771 (Published 29 December 2016) Cite this as: BMJ 2016;355:i6771